CEO of Achillion Pharmaceuticals Inc (30-Year Financial, Insider Trades) Joseph Truitt (insider trades) sold 133,484 shares of ACHN on 10/16/2019 at an average price of $6.37 a share. The total sale was $850,293.
Achillion Pharmaceuticals Inc is a biotechnology company. It is engaged in the discovery and development of innovative small-molecule drug therapies for infectious diseases and immune system disorders. Achillion Pharmaceuticals Inc has a market cap of $851.960 million; its shares were traded at around $6.09 . Achillion Pharmaceuticals Inc had annual average EBITDA growth of 11.30% over the past ten years. GuruFocus has detected 3 severe warning signs with Achillion Pharmaceuticals Inc. .
CEO Recent Trades:
- CEO Joseph Truitt sold 133,484 shares of ACHN stock on 10/16/2019 at the average price of $6.37. The price of the stock has decreased by 4.4% since.
For the complete insider trading history of ACHN, click here
.